Cole12 September 5th, 2017 8:15pm
When investors short sell biotech stocks, it pushes down the share price, making it difficult for these companies to raise capital to fund drug development. As a result, life saving drugs may never be created. Is it unethical to short biotechs?
Comments: Add Comment